Quality of T-cell responses versus reduction in viral load: results from an exploratory phase II clinical study of Vacc-4x, a therapeutic HIV vaccine

被引：0
|
作者：
Ellefsen-Lavoie, K. [1 ]
Rockstroh, J. [2 ]
Pollard, R. [3 ]
Pantaleo, G. [1 ]
Podzamczer, D. [4 ]
Asmuth, D. [3 ]
van Lunzen, J. [5 ]
Arasteh, K. [6 ]
Schuemann, D. [7 ]
Peters, B. [8 ]
Clotet, B. [9 ]
Hardy, D. [10 ]
Lazzarin, A. [11 ]
Gatell, J. [12 ]
Sommerfelt, M. A. [13 ]
Baksaas, I. [14 ]
Wendel-Hansen, V. [15 ]
Sorensen, B. [15 ]
机构：
[1] Univ Lausanne, Lausanne, Switzerland
[2] Univ Bonn, Bonn, Germany
[3] Univ Calif Davis, Davis, CA 95616 USA
[4] Univ Bellvitge, Barcelona, Spain
[5] Univ Klinikum Hamburg Eppendorf, Hamburg, Germany
[6] EPIMED, Berlin, Germany
[7] Charite Virchow Klinikum, Berlin, Germany
[8] Guys & St Thomas Hosp, London SE1 9RT, England
[9] Hosp Badalona Germans Trias & Pujol, Badalona, Spain
[10] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
[11] Univ Vita Salute San Raffaele, Milan, Italy
[12] Hosp Clin Barcelona, Barcelona, Spain
[13] Bionor Pharma ASA, Oslo, Norway
[14] Mericon, Skien, Norway
[15] Bionor Pharma, Oslo, Norway
来源：
RETROVIROLOGY | 2012年 / 9卷
关键词：
Placebo; Placebo Group; Viral Load; Exploratory Phase; Therapeutic Vaccine;
D O I：
10.1186/1742-4690-9-S2-O66
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
收藏
页数：1
相关论文
共 28 条
  • [1] Quality of T-cell responses versus reduction in viral load: results from an exploratory phase II clinical study of Vacc-4x, a therapeutic HIV vaccine
    K Ellefsen-Lavoie
    J Rockstroh
    R Pollard
    G Pantaleo
    D Podzamczer
    D Asmuth
    J van Lunzen
    K Arastéh
    D Schürmann
    B Peters
    B Clotet
    D Hardy
    A Lazzarin
    J Gatell
    MA Sommerfelt
    I Baksaas
    V Wendel-Hansen
    B Sørensen
    Retrovirology, 9
  • [2] Re-boost immunizations with the peptide-based therapeutic HIV vaccine, Vacc-4x, restores geometric mean viral load set-point during treatment interruption
    Rockstroh, Juergen K.
    Asmuth, David
    Pantaleo, Giuseppe
    Clotet, Bonaventura
    Podzamczer, Daniel
    van Lunzen, Jan
    Arasteh, Keikawus
    Mitsuyasu, Ronald
    Peters, Barry
    Silvia, Nozza
    Jolliffe, Darren
    Okvist, Mats
    Krogsgaard, Kim
    Sommerfelt, Maja A.
    PLOS ONE, 2019, 14 (01):
  • [3] The therapeutic HIV Env C5/gp41 vaccine candidate Vacc-C5 induces specific T cell regulation in a phase I/II clinical study
    Brekke, Kristin
    Sommerfelt, Maja
    Okvist, Mats
    Dyrhol-Riise, Anne Margarita
    Kvale, Dag
    BMC INFECTIOUS DISEASES, 2017, 17
  • [4] The therapeutic HIV Env C5/gp41 vaccine candidate Vacc-C5 induces specific T cell regulation in a phase I/II clinical study
    Kristin Brekke
    Maja Sommerfelt
    Mats Ökvist
    Anne Margarita Dyrhol-Riise
    Dag Kvale
    BMC Infectious Diseases, 17
  • [5] Cell- Mediated Immune Predictors of Vaccine Effect on Viral Load and CD4 Count in a Phase 2 Therapeutic HIV-1 Vaccine Clinical Trial
    Huang, Yunda
    Pantaleo, Giuseppe
    Tapia, Gonzalo
    Sanchez, Brittany
    Zhang, Lily
    Trondsen, Monica
    Hovden, Arnt-Ove
    Pollard, Richard
    Rockstroh, Juergen
    Okvist, Mats
    Sommerfelt, Maja A.
    EBIOMEDICINE, 2017, 24 : 195 - 204
  • [6] Postvaccination C-Reactive Protein and C5/gp41732-744 Antibody Level Fold-Changes Over Baseline Are Independent Predictors of Therapeutic HIV Vaccine Effect in a Phase 2 Clinical Study of Vacc-4x
    Huang, Yunda
    Zhang, Lily
    Jolliffe, Darren
    Sanchez, Brittany
    Stjernholm, Grete
    Jelmert, Oyvind
    Okvist, Mats
    Sommerfelt, Maja A.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2018, 34 (03) : 307 - 313
  • [7] A dendritic cell-based vaccine effects on T-cell responses compared with a viral vector vaccine when administered to patients following resection of colorectal metastases in a randomized phase II study.
    Lyerly, H. K.
    Hobeika, A.
    Niedzwiecki, D.
    Osada, T.
    Marshall, J.
    Garrett, C. R.
    Chang, D. Z.
    Aklilu, M.
    Crocenzi, T. S.
    Cole, D. J.
    Dessureault, S.
    Hsu, S. D.
    Bulusu, A.
    Clary, B. M.
    Annechiarico, R.
    Devi, G.
    Chadaram, V.
    Clay, T. M.
    Morse, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [8] Validation of CD4+ T-cell and viral load data from the HIV-Brazil Cohort Study using secondary system data
    Flores Cassenote, Alex Jones
    Grangeiro, Alexandre
    Escuder, Maria Mercedes
    Abe, Jair Minoro
    Cotrim Segurado, Aluisio Augusto
    BMC INFECTIOUS DISEASES, 2018, 18
  • [9] Validation of CD4+ T-cell and viral load data from the HIV-Brazil Cohort Study using secondary system data
    Alex Jones Flores Cassenote
    Alexandre Grangeiro
    Maria Mercedes Escuder
    Jair Minoro Abe
    Aluísio Augusto Cotrim Segurado
    BMC Infectious Diseases, 18
  • [10] Impact of adjuvants on CD4+ T cell and B cell responses to a protein antigen vaccine: Results from a phase II, randomized, multicenter trial
    Leroux-Roels, Geert
    Marchant, Arnaud
    Levy, Jack
    Van Damme, Pierre
    Schwarz, Tino F.
    Horsmans, Yves
    Jilg, Wolfgang
    Kremsner, Peter G.
    Haelterman, Edwige
    Clement, Frederic
    Gabor, Julian J.
    Esen, Meral
    Hens, Annick
    Carletti, Isabelle
    Fissette, Laurence
    Da Silva, Fernanda Tavares
    Burny, Wivine
    Janssens, Michel
    Moris, Philippe
    Didierlaurent, Arnaud M.
    Van der Most, Robbert
    Garcon, Nathalie
    Van Belle, Pascale
    Van Mechelen, Marcelle
    CLINICAL IMMUNOLOGY, 2016, 169 : 16 - 27
123